뒤로
Fujian Haixi Pharmaceuticals Co., Ltd.(02637.HK) 가격
02637.HK 주가 차트
HAIXI PHARMA (02637.HK)
Fujian Haixi Pharmaceuticals Co., Ltd.
HK$157.5
-2.53%
$-4.09
정규장: Jan 19, 13:34:13 HKT
아직 데이터 없음Follow-Up Questions
Fujian Haixi Pharmaceuticals Co., Ltd.의 주요 재무제표는 무엇인가요?
02637.HK의 주요 재무 비율은 무엇인가요?
Fujian Haixi Pharmaceuticals Co., Ltd.의 매출은 부문 또는 지역별로 어떻게 나뉘나요?
Fujian Haixi Pharmaceuticals Co., Ltd.은 수익성이 있나요?
Fujian Haixi Pharmaceuticals Co., Ltd.에 부채가 있나요?
Fujian Haixi Pharmaceuticals Co., Ltd.의 발행 주식은 몇 주인가요?
주요 통계
이전 종가
$161.5
시가
$161.6
일일 범위
$147.5 - $161.6
52주 범위
$97.5 - $157.5
거래량
46.0K
평균 거래량
137.3K
EPS(TTM)
--
배당수익률
--
시가총액
$12.3B
HAIXI PHARMA란 무엇인가요?
Fujian Haixi New Drug Creation Co., Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products. The company is headquartered in Fuzhou, Fujian. The company went IPO on 2025-10-20. The Company’s main products include Anbili, Haihuitong, Ruiantuo and Saixifu. The Company’s products are mainly used in digestive system diseases, cardiovascular system diseases, endocrine system diseases, nervous system diseases, inflammatory diseases, oncology, ophthalmology, respiratory diseases and others. The firm mainly operates its businesses in the domestic market.